Sign In

David Pearlman

Vice President of Product at QSimulate

David Pearlman is a pioneering computational chemist known for his primary contributions to major molecular modeling platforms like AMBER, Schrodinger, and Discovery Studio.

With an extensive background in computational chemistry, protein and antibody design, software program management, and structure-based drug design, David has a proven track record of success in the industry.

His milestones include being the first author of multiple versions of Amber, a widely used molecular modeling package, and developing the successful BioLuminate biologics structure design platform for Schrödinger.

David's communication skills, technical expertise, and ability to manage multiple clients make him a valuable asset in the field.

He holds a B.S. in Chemistry from Stanford University, a Ph.D. in Chemistry from the University of California, Berkeley, and has completed a Post Doc in Computational Chemistry at the University of California, San Francisco.

Throughout his career, David has held key positions at organizations like QSimulate, Cyrus Biotechnology, Schrodinger, Vertex Pharmaceuticals, and Biosym Technologies.

His contributions to methodology development, free energy calculations, NMR refinement methods, and molecular dynamics have significantly impacted the industry.

In addition to his work in computational chemistry, David was the first person to provide a formal avenue for music promotion on the Internet.

With a focus on computational chemistry, molecular modeling, and protein design, David Pearlman continues to be a leading figure in the field, combining his technical expertise with exceptional writing and verbal skills.

David Pearlman
Add to my network

Location

Lexington, Massachusetts, United States